Marcus Couey
Providence Portland Medical Center
16 Papers
8 Citations
Marcus Couey is an academic researcher from Providence Portland Medical Center. The author has contributed to research in topics: Cancer & Head and neck cancer. The author has an hindex of 3, co-authored 11 publications.
Chat about Author
Papers
Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance
Marcus Couey,R. Bryan Bell,Ashish A. Patel,Meghan C. Romba,Marka R. Crittenden,Brendan D. Curti,Walter J. Urba,Rom Leidner +7 more
TL;DR: Delayed immune-related events (DIRE) should figure prominently in the differential diagnosis of patients presenting with illnesses of unclear etiology, irrespective of intervening treatments or interval post-immunotherapy, both of which can confound diagnosis.
176
Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma.
Rom Leidner,Marka R. Crittenden,Kristina H. Young,Hong Xiao,Yaping Wu,Marcus Couey,Ashish A. Patel,Allen C. Cheng,Amber L. Watters,Carlo Bifulco,George Morris,Lessli Rushforth,Shorin Nemeth,Walter J. Urba,Michael J. Gough,R. Bryan Bell +15 more
TL;DR: The Neoadjuvant Immuno-Radiotherapy Trial as mentioned in this paper was an investigator-initiated single institution phase Ib clinical trial that enrolled patients with previously untreated locally advanced head and neck squamous cell carcinoma between 2018 and 2019.
110
Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors.
Corey C. Foster,Marcus Couey,Sara Kochanny,Arun Khattri,Rajesh Acharya,Yi-Hung Carol Tan,Ryan J. Brisson,Rom Leidner,Tanguy Y. Seiwert +8 more
TL;DR: In this article, the authors found that patients developing immune-related adverse events (irAEs) while receiving immune checkpoint inhibition (ICI) for recurrent/metastatic head and neck cancer would have improved oncologic outcomes.
Transoral robotic surgery and neck dissection for HPV-positive oropharyngeal carcinoma: Importance of nodal count in survival
Chi T. Viet,Eric J. Dierks,Allen C. Cheng,Ashish A. Patel,Shu-Ching Chang,Marcus Couey,Amber L. Watters,Thien Hoang,Hong D. Xiao,Marka R. Crittenden,Rom Leidner,Steven K. Seung,Kristina H. Young,R. Bryan Bell +13 more
TL;DR: The study demonstrates that surgery could be simplified by performing TORS with SND rather than MRND, and the one true poor prognostic factor in HPV-positive oropharyngeal carcinoma patients who undergo surgery is high nodal burden.
13
Chemoradiation therapy alters the PD-L1 score in locoregional recurrent squamous cell carcinomas of the head and neck.
B J Park,Austin Mattox,Daniel R. Clayburgh,Mihir R. Patel,R. Bryan Bell,Bevan Yueh,Rom Leidner,Hong Xiao,Marcus Couey,Shiting Li,Tingting Qin,Maureen A. Sartor,Belinda Cairns,Tracy MacDonough,Kyle D. Halliwill,Daniel G. Deschler,Derrick T. Lin,William C. Faquin,Peter M. Sadow,Sara I. Pai +19 more
TL;DR: In this paper , the authors evaluated whether chemoradiation therapy (CRT) influences PD-L1 combined positive score (CPS) and other biomarkers of response to immunotherapy.
5